Claritin Tablet, Orally Disintegrating
Product Images NDC 11523-7202

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Claritin (NDC 11523-7202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Back Carton Label (10 Count Outer Container Label Cropped 2)

FDA Label Image

Front Label (10 Count Outer Container Label Cropped)

Front Label (10 Count Outer Container Label Cropped)
This is a product description of 10 oRALLY DISINTEGRATING TABLETS used for relieving symptoms such as sneezing, runny nose, itchy and watery eyes as well as itchy throat or nose. The tablets are non-drowsy and come in an 81z 14]1] 1K Redamabs pack. Usage instructions are illegible.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.